The Cost-effectiveness of Pre-Exposure Prophylaxis for HIV Infection in South African Women | Zendy

Rochelle P. Walensky | Zendy; J.-E. Park | Zendy; Rachel C. Wood | Zendy; Kenneth A. Freedberg | Zendy; Catherine Scott | Zendy; LindaGail Bekker | Zendy; Elena Losina | Zendy; K. H. Mayer | Zendy; George R. Seage | Zendy; A. David Paltiel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Cost-effectiveness of Pre-Exposure Prophylaxis for HIV Infection in South African Women

Author(s) -

Rochelle P. Walensky,

J.-E. Park,

Rachel C. Wood,

Kenneth A. Freedberg,

Catherine Scott,

LindaGail Bekker,

Elena Losina,

K. H. Mayer,

George R. Seage,

A. David Paltiel

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis225

Subject(s) - medicine , human immunodeficiency virus (hiv) , pre exposure prophylaxis , sida , immunology , intensive care medicine , virology , viral disease , men who have sex with men , syphilis

Recent trials report the short-term efficacy of tenofovir-based pre-exposure prophylaxis (PrEP) for prevention of human immunodeficiency virus (HIV) infection. PrEP's long-term impact on patient outcomes, population-level transmission, and cost-effectiveness remains unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research